Cancer Chemotherapy and Pharmacology

, Volume 28, Issue 5, pp 339–343 | Cite as

Antiproliferative activity of purine nucleoside dialdehydes against leukemia L1210 in vitro

  • Bertrum Sheid
  • Mitu Saggar
  • Eric Gaetjens
  • Leon M. Lerner
Original Articles Nucloside Dialdehydes, Antileukemic Activity, C1210 Cells


Sixteen purine nucleoside dialdehydes were assayed for antiproliferative activity against murine leukemia L1210 grown in vitro. These compounds either lacked the terminal hydroxymethyl group that is necessary in most cases for phosphorylation, and/or had stereochemically different configurations at one or two positions, or had some alteration in the purine ring structure. Among the latter were two lipophilic N6-benzyladenine containing dialdehydes, and two nucleoside dialdehydes with a bromine atom at C-8 of the purine. These nucleoside dialdehydes, unlike most clinically useful anticancer nucleosides, did not require enzymatic phosphorylation to become activated. The most interesting agent in this group of compounds was the lipophilic nucleoside dialdehyde obtained from N6-benzyladenosine after periodate oxidation. It had an IC50 of 1.0±0.2 μm, and appears to function by limiting the formation of deoxyguanosine diphosphate (dGDP) by inhibition of ribonucleoside diphosphate reductase, the rate limiting step in the biosynthesis of deoxyribonucleotides.


Purine Nucleoside Bromine Diphosphate Periodate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arezzo F (1987) Determination of ribonucleoside triphosphates and deoxyribonucleoside triphosphates in Novikoff hepatoma cells by high-performance liquid chromatography. Anal Biochem 160:57Google Scholar
  2. 2.
    Blackburn GM, Johnson AW (1960) The synthesis of 7-glycosyl-purines: I. Synthesis from purines. J Chem Soc 4347Google Scholar
  3. 3.
    Brooks BR, Klamerth OL (1968) Interaction of DNA with bifunctional dialdehydes. Eur J Biochem 5:178Google Scholar
  4. 4.
    Calabresi P, Parks RE (1980) Chemotherapy of neoplastic diseases. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 1276–1287Google Scholar
  5. 5.
    Cory JC, Mansell MM, Whitford TW Jr (1976) Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine and inosinic acid. Cancer Res 36:3166Google Scholar
  6. 6.
    Cysyk RL, Adamson RH (1974) Antitumor properties and pharmacological disposition of inosine dialdehyde. Proc Am Assoc Cancer Res 15:56Google Scholar
  7. 7.
    Cysyk RL, Adamson RH (1976) Protein cross-linking properties of the antitumor agent inosine dialdehyde (NSC 118 994). Cancer Treat Rep 60:563Google Scholar
  8. 8.
    Davoll J, Lowy BA (1952) Some synthetic analogs of the natural purine nucleosides. J Am Chem Soc 74:1563Google Scholar
  9. 9.
    Dvonch W, Fletcher H III, Gregory FJ, Healy EH, Warren GH, Alburn HE (1966) Antitumor activity of periodate oxidation products of carbohydrates and their derivatives. Cancer Res 26:2386Google Scholar
  10. 10.
    Fleysher MH, Bloch A, Hakada MT, Nichol CA (1969) Synthesis and biological activity of some new N6-substituted purine nucleosides. J Med Chem 12:1056Google Scholar
  11. 11.
    Garret C, Santi DV (1979) A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem 99:268Google Scholar
  12. 12.
    Grant AJ (1979) The biochemical activity of aldehydes derived from nucleosides. PhD thesis, New York, (State University of New York, Downstate Medical Center: Dissert Abst Int 40:3135B, 1980)Google Scholar
  13. 13.
    Grant AJ, Lerner LM (1979) Dialdehydes derived from adenine nucleosides as substrates and inhibitors of adenosine aminohydrolase. Biochemistry 18:2838Google Scholar
  14. 14.
    Grant AJ, Lerner LM (1980) Heat-induced formation of α,β-unsaturated nucleoside dialdehydes and their activity with adenosine deaminase. J Med Chem 23:795Google Scholar
  15. 15.
    Harmenberg J, Karlsson AHJ, Gilljam G (1987) Comparison of sample preparation methods for the high-performance liquid chromatographic analysis of cell culture extracts for triphosphate ribonucleosides and deoxyribonucleosides. Biochemistry 161:26Google Scholar
  16. 16.
    Jackson RC (1984) A kinetic model of regulation of the deoxyribonucleoside triphosphate pool composition. Pharmacol Ther 24:279Google Scholar
  17. 17.
    Jones AS, Markham AF, Walker RT (1976) A simple method for the preparation of ribonucleoside dialdehydes and some comments on their structure. J Chem Soc [Perkin Trans] 1:1567Google Scholar
  18. 18.
    Kaufman J, Mittleman I (1975) Clinical phase I trial of inosine dialdehyde (NSC 118 994). Cancer Treat Rep 59:1007Google Scholar
  19. 19.
    Khym JX (1975) An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers. Clin Chem 21:1245Google Scholar
  20. 20.
    Khym JX, Cohn WE (1960) Characterizations and some chemical reactions of periodate-oxidized nucleosides. J Am Chem Soc 82:6380Google Scholar
  21. 21.
    Kimball AP, Wilson MJ, Bell JP, LePage GA (1968) Inhibition of thymidylate kinase and DNA polymerase by the periodate oxidation products of β-d-ribosyl-6-methylthiopurine. Cancer Res 28:661Google Scholar
  22. 22.
    Lee MH, Lazo JS, Li C-D, Hadfield AF, Maniglia CA, Sartorelli AC (1982) Solubilization of murine melanoma xylosyltransferase and galactosyltransferase activities and their inactivation by dialdehyde nucleosides. Chem Biol Interact 41:141Google Scholar
  23. 23.
    Lerner LM, Sheid B, Gaetjens E (1987) Preparation and antileukemic screening of some new 6′-deoxyhexopyranosyladenine nucleosides. J Med Chem 30:1521Google Scholar
  24. 24.
    Mehler AH, Kim J-JP, Olsen AA (1981) Specificity in the inactivation of enzymes by periodate-oxidized nucleotides. Arch Biochem Biophys 212:475Google Scholar
  25. 25.
    O'Dea RF, Mirkin BL, Hogenkamp HP, Barton DM (1987) Effect of adenosine analogues on protein carboxymethyltransferase,S-adenosylhomocysteine hydrolase and ribonucleotide reductase activity in murine neuroblastoma cells. Cancer Res 47:3656Google Scholar
  26. 26.
    Ohmstead CA, Cory JG (1985) Effect of the dialdehyde derivative of 5′-deoxyinosine on pyrimidine deoxyribonucleoside metabolism in L1210 cells. Biochem Pharmacol 34:1117Google Scholar
  27. 27.
    Plageman PGW, Graff JC, Behrens M (1979) Mechanism of action of inosine dialdehyde (NSC 118 994) in the inhibition of proliferation of tumor cells in culture. Cancer Res 37:2188Google Scholar
  28. 28.
    Sheid B, Lerner LM, Gaetjens E (1989) Antiproliferative effects of 4′,5′-unsaturated adenine nucleosides on leukemia L1210 cells in vitro. Experientia 45:729Google Scholar
  29. 29.
    Sheid B, Prat JC, Gaetjens E (1989) A tumor growth inhibitory factor and a tumor growth promoting factor isolated from unfertilized ova of Shad (Alosa sapidissima). Biochem Biophys Res Commun 159:713Google Scholar
  30. 30.
    Show-Chen C, Brown PR, Rosie DM (1977) Extraction procedures for use prior to HPLC nucleotide analysis using microparticle chemically bonded packings. J Chromatogr Sci 15:218Google Scholar
  31. 31.
    Sorace RA, Sheid B (1979) Cytotoxic effects of the lysosomotropic agents DNA ellipticine, DNA-daunorubicin and DNA-ellipticine: daunorubicin on L1210 leukemia cells. Cancer Treat Rep 63:43Google Scholar
  32. 32.
    Spoor TC, Evans JE, Kimball AP (1971) DNA-dependent RNA polymerase inhibition of a mammalian enzyme by methylthioinosine dialdehyde. Proc Soc Exp Med 136:605Google Scholar
  33. 33.
    Spoor TC, Hodnett JL, Kimball AP (1973) The molecular mechanism of action of methylthioinosine dicarboxaldehyde on ribonucleose A as a model system. Cancer Res 33:856Google Scholar
  34. 34.
    Srivastava VK, Pall ML, Schroeder AL (1988) Deoxyribonucleotide triphosphate pools in Neurospora crassa: effects of histidine and hydroxyurea. Mutat Res 200:45Google Scholar
  35. 35.
    Tanaka K, Yoshioka A, Tanaka S, Wataya Y (1984) An improved method for the quantitative determination of deoxyribonucleoside triphosphates in cell extracts. Anal Biochem 139:35Google Scholar
  36. 36.
    Tsai RK, Hoagenkamp HPC (1983) Affinity labelling of ribonucleotide reductase by the 2′,3′-dialdehyde derivatives of ribonucleotides. Arch Biochem Biophys 226:276Google Scholar
  37. 37.
    Wright JA, Alam TG, McClarty GA (1987) Altered expression of ribonucleotide reductase and role of M2 gene amplification in hydroxyurea-resistant hamster, mouse, rat and human cell lines. Somat Cell Mol Genet 13:155Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • Bertrum Sheid
    • 3
  • Mitu Saggar
    • 3
  • Eric Gaetjens
    • 1
  • Leon M. Lerner
    • 2
  1. 1.Department of PathologyHealth Science Center at Brooklyn, SUNYBrooklynUSA
  2. 2.Department of BiochemistryHealth Science Center at Brooklyn, SUNYBrooklynUSA
  3. 3.Department of PharmacologyHealth Science Center at BrooklynBrooklynUSA

Personalised recommendations